Canadian Class Action Lawsuit Claims Zyprexa Causes Diabetes

Source: Canada NewsWire Group

Published: February 02, 2005

A British Columbia man last week filed a class action lawsuit against drug maker Eli Lilly, alleging the company "purposefully minimized and understated health hazards and risks associated with Zyprexa." ... Zyprexa resulted in diabetes... Eli Lilly falsely and fraudulently withheld relevant information ... who has suffered the negative consequences of using either Celebrex or Zyprexa...

ZYPREXA, manufactured by Eli Lilly and Company, and distributed in Canada since 1996, is among a group of drugs called the "atypical antipsychotic drugs" prescribed for the treatment of certain disorders, including schizophrenia and bipolar disorder. It blocks the action of serotonin and dopamine, producing a tranquilizing and antipsychotic effect.

"Eli Lilly purposefully minimized and understated health hazards and risks associated with Zyprexa. Eli Lilly, through literature and oral statements, deceived potential users of Zyprexa and their physicians by relaying positive information, including testimonials from satisfied users and by manipulating statistics to suggest widespread acceptability, while downplaying the known adverse and serious health effects of the drug. Eli Lilly falsely and fraudulently withheld relevant information from potential users of Zyprexa."